These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 27542337)

  • 21. Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional study.
    Arribas-Ibar E; Sánchez-Niubò A; Majó X; Domingo-Salvany A; Brugal MT
    Harm Reduct J; 2014 Nov; 11(1):33. PubMed ID: 25416534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid overdose prevention in a residential care setting: Naloxone education and distribution.
    Pade P; Fehling P; Collins S; Martin L
    Subst Abus; 2017; 38(1):113-117. PubMed ID: 27093647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving Outcomes of Opioid Overdose: Preparing Nursing Students to Intervene.
    Dion KA
    J Addict Nurs; 2016; 27(1):7-11. PubMed ID: 26950837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention.
    Kirane H; Ketteringham M; Bereket S; Dima R; Basta A; Mendoza S; Hansen H
    J Subst Abuse Treat; 2016 Oct; 69():44-9. PubMed ID: 27568509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A qualitative evaluation of a peer-implemented overdose response pilot project in Gejiu, China.
    Bartlett N; Xin D; Zhang H; Huang B
    Int J Drug Policy; 2011 Jul; 22(4):301-5. PubMed ID: 21658931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute stressors and clinical characteristics differentiate death by suicide, accident, or natural causes among illicit and prescription opiate users.
    Athey AJ; Beale EE; Overholser JC; Stockmeier CA; Bagge CL
    Drug Alcohol Depend; 2020 Mar; 208():107847. PubMed ID: 31951908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.
    Bazazi AR; Zelenev A; Fu JJ; Yee I; Kamarulzaman A; Altice FL
    Int J Drug Policy; 2015 Jul; 26(7):675-81. PubMed ID: 25532449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of overdose prevention trainings in New York City: Knowledge and self-efficacy among participants 12 months after training.
    Maldjian L; Siegler A; Kunins HV
    Subst Abus; 2016; 37(3):459-465. PubMed ID: 26731134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.
    Ashrafioun L; Gamble S; Herrmann M; Baciewicz G
    Subst Abus; 2016; 37(1):76-81. PubMed ID: 26514071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
    Kelty E; Hulse G
    Int J Drug Policy; 2017 Aug; 46():54-60. PubMed ID: 28609749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The study of characteristics of overdose among users of opioid drug injections].
    Iliuk RD; Krupitskiĭ EM; Torban MN; Kozlov AP; Blinnikova KN; Heimer R; Green T; Grau LE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 2):33-43. PubMed ID: 21322146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and Management of Patients with Heroin versus Nonheroin Opioid Overdoses: Experience at an Academic Medical Center.
    Morizio KM; Baum RA; Dugan A; Martin JE; Bailey AM
    Pharmacotherapy; 2017 Jul; 37(7):781-790. PubMed ID: 28100012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demographic, geographic, and temporal patterns of ambulance runs for suspected opiate overdose in Rhode Island, 1997-20021.
    Merchant RC; Schwartzapfel BL; Wolf FA; Li W; Carlson L; Rich JD
    Subst Use Misuse; 2006; 41(9):1209-26. PubMed ID: 16861173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    Addiction; 2015 Aug; 110(8):1301-10. PubMed ID: 25917125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.
    Beletsky L; Ruthazer R; Macalino GE; Rich JD; Tan L; Burris S
    J Urban Health; 2007 Jan; 84(1):126-36. PubMed ID: 17146712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coping with the enduring unpredictability of opioid addiction: An investigation of a novel family-focused peer-support organization.
    Kelly JF; Fallah-Sohy N; Cristello J; Bergman B
    J Subst Abuse Treat; 2017 Jun; 77():193-200. PubMed ID: 28222927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths.
    Rando J; Broering D; Olson JE; Marco C; Evans SB
    Am J Emerg Med; 2015 Sep; 33(9):1201-4. PubMed ID: 26095132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience of heroin overdose among drug users attending general practice.
    Cullen W; Bury G; Langton D
    Br J Gen Pract; 2000 Jul; 50(456):546-9. PubMed ID: 10954935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing naloxone for opioid overdose intervention.
    Dunne RB
    Pain Manag; 2018 May; 8(3):197-208. PubMed ID: 29667859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.